UAE Peripheral Vascular Devices Market - Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Market Overview
The UAE peripheral vascular devices market is anticipated to expand from USD 22.13 million in 2023 to USD 30.69 million by 2032, registering a compound annual growth rate (CAGR) of 4.17% over the forecast period.

Growth in this market is primarily fueled by the increasing incidence of vascular disorders, such as peripheral artery disease (PAD), largely driven by the rising prevalence of diabetes, obesity, and hypertension in the region. The expanding elderly population further amplifies the demand for advanced medical interventions, supporting the uptake of minimally invasive techniques. Government-led enhancements in healthcare infrastructure and a rise in healthcare spending bolster this upward trend. In addition, technological progress in device innovation—such as drug-coated balloons and advanced stents—has significantly improved patient outcomes, encouraging greater utilization. The market also gains momentum from improved early detection rates through more effective screening programs. Key market trends include a shift toward tailored treatment strategies and a growing focus on the development of bioresorbable stents to reduce long-term risks. The increasing preference for outpatient vascular interventions and the strengthening collaboration between medical institutions and device manufacturers are expected to unlock substantial growth opportunities in the near future.

Market Drivers
Rising Incidence of Peripheral Artery Disease and Related Conditions
The UAE’s increasing burden of peripheral artery disease (PAD) and associated vascular conditions is a major growth catalyst for the peripheral vascular devices market. Escalating cases linked to common risk factors—such as diabetes, obesity, and high blood pressure—underscore the need for effective treatment solutions. A study by Gulf Medical University reports that PAD affects 22.7% of adults aged 40 and above in the UAE, with prevalence highest among individuals aged 60 and older. Sedentary lifestyles and evolving habits are further exacerbating these health issues, prompting healthcare providers to embrace advanced vascular treatment technologies. Consequently, the demand for devices such as stents, angioplasty balloons, and atherectomy systems is steadily increasing to manage these complex conditions.

Market Challenges Analysis
Elevated Costs of Advanced Devices and Procedures
The substantial cost associated with cutting-edge peripheral vascular devices and minimally invasive treatments remains a significant barrier in the UAE market. High-end technologies, including drug-coated balloons, bioresorbable stents, and atherectomy systems, are often priced at a premium, restricting access for specific patient groups. For instance, a drug-coated balloon in the UAE can cost between AED 10,000 and AED 15,000. Despite strides in infrastructure and broader insurance coverage, affordability issues persist, particularly for procedures lacking full reimbursement. Moreover, healthcare institutions encounter financial challenges when acquiring advanced equipment and conducting training, which can inhibit broader adoption. Achieving a balance between cost-efficiency and technological advancement remains a core challenge for stakeholders.

Segments

By Type:

Angioplasty Balloons

Angioplasty Stents

Catheters

Guidewires

Others

By End-user:

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

By Geography:

Abu Dhabi

Dubai

Sharjah

Ajman

Fujairah

Ras Al Khaimah

Umm Al Quwain

Key Player Analysis

Medtronic plc

Abbott Laboratories

Boston Scientific Corporation

Becton, Dickinson and Company

Terumo Corporation

Biotronik SE & Co. KG

Cook Medical

L. Gore & Associates, Inc.

Cardinal Health

AngioDynamics, Inc.

Show more